Intravesical hyaluronic acid with chondroitin sulphate to prevent urinary tract infection after spinal cord injury

References

• Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016;5(1):72–87.
   PubMed Web of Science ®Google Scholar
• Cardenas DD, Hoffman JM, Kirshblum S, McKinley W. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil 2004;85(11):1757–1763.
   PubMed Web of Science ®Google Scholar
• DeJong G, Tian W, Hsieh CH, Junn C, Karam C, Ballard PH, et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil 2013;94(4 Suppl):S87–S97.
   PubMed Web of Science ®Google Scholar
• Gabbe BJ, Nunn A. Profile and costs of secondary conditions resulting in emergency department presentations and readmission to hospital following traumatic spinal cord injury. Injury 2016;47(8):1847–1855.
   PubMed Web of Science ®Google Scholar
• Watts A. (2012). An audit of readmissions of people with spinal cord injury to a major metropolitan teaching hospital in Perth, Western Australia.
   Google Scholar
• Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002;113(Suppl 1A):67S–79S.
   PubMedGoogle Scholar
• Esclarin De Ruz A, Garcia Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000;164(4):1285–1289.
   PubMed Web of Science ®Google Scholar
• Roth JD, Pariser JJ, Stoffel JT, Lenherr SM, Myers JB, Welk B, et al. Patient subjective assessment of urinary tract infection frequency and severity is associated with bladder management method in spinal cord injury. Spinal Cord 2019;57(8):700–707.
   PubMed Web of Science ®Google Scholar
• Stillman MD, Barber J, Burns S, Williams S, Hoffman JM. Complications of spinal cord injury over the first year after discharge from inpatient rehabilitation. Arch Phys Med Rehabil 2017;98(9):1800–1805.
   PubMed Web of Science ®Google Scholar
• Garcia-Arguello LY, O'Horo JC, Farrell A, Blakney R, Sohail MR, Evans CT, et al. Infections in the spinal cord-injured population: a systematic review. Spinal Cord 2017;55(6):526–534.
   PubMed Web of Science ®Google Scholar
• Jahromi MS, Mure A, Gomez CS. UTIs in patients with neurogenic bladder. Curr Urol Rep 2014;15(9):433.
   PubMedGoogle Scholar
• Goodes LM, King GK, Rea A, Murray K, Boan P, Watts A, et al. Early urinary tract infection after spinal cord injury: a retrospective inpatient cohort study. Spinal Cord 2020;58(1):25–34.
   PubMed Web of Science ®Google Scholar
• Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther Adv Urol 2011;3(5):223–232.
   PubMedGoogle Scholar
• Apodaca G, Kiss S, Ruiz W, Meyers S, Zeidel M, Birder L. Disruption of bladder epithelium barrier function after spinal cord injury. Am J Physiol Renal Physiol 2003;284(5):F966–F976.
   PubMed Web of Science ®Google Scholar
• Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans–a review. Neurourol Urodyn 2013;32(1):9–18.
   PubMed Web of Science ®Google Scholar
• Manas A, Glaria L, Pena C, Sotoca A, Lanzos E, Fernandez C, et al. Prevention of urinary tract infections in palliative radiation for vertebral metastasis and spinal compression: a pilot study in 71 patients. Int J Radiat Oncol Biol Phys 2006;64(3):935–940.
   PubMed Web of Science ®Google Scholar
• Cicek N, Yildiz N, Alpay H. Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder. J Pediatr Urol 2020;16(3):366.e1–366.e5.
   PubMed Web of Science ®Google Scholar
• Havloka K, Rejchrt M, Kriz J. Prevention of recurrent urinary tract infections with the use of intravesical instillation of hyaluronic acid and chondroitin sulfate in patients after spinal cord injury. Eur Urol Suppl 2016;15(11):e1441.
   Google Scholar
• Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50(5):625–663.
   PubMed Web of Science ®Google Scholar
• Tulsky DS, Kisala PA, Tate DG, Spungen AM, Kirshblum SC. Development and psychometric characteristics of the SCI-QOL Bladder Management Difficulties and bowel Management Difficulties item banks and short forms and the SCI-QOL Bladder Complications scale. J Spinal Cord Med 2015;38(3):288–302.
   PubMed Web of Science ®Google Scholar
• Tulsky DS, Kisala PA, Victorson D, Tate DG, Heinemann AW, Charlifue S, et al. Overview of the spinal cord injury–quality of life (SCI-QOL) measurement system. J Spinal Cord Med 2015;38(3):257–269.
   PubMed Web of Science ®Google Scholar
• Locke JA, Welk B, Macnab A, Rivers CS, Kurban D, Nigro M, et al. Exploring the relationship between self-reported urinary tract infections to quality of life and associated conditions: insights from the spinal cord injury community survey. Spinal Cord 2019;57(12):1040–1047.
   PubMed Web of Science ®Google Scholar
• Goddard JC, Janssen DAW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J 2018;29(7):933–942.
   PubMed Web of Science ®Google Scholar
• Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin BH, Montgomerie J, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002;83(1):129–138.
   PubMed Web of Science ®Google Scholar
• Salomon J, Denys P, Merle C, Chartier-Kastler E, Perronne C, Gaillard JL, et al. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up–an observational prospective study. J Antimicrob Chemother 2006;57(4):784–788.
   PubMed Web of Science ®Google Scholar
• Arreola-Guerra JM, Rosado-Canto R, Alberu J, Maravilla E, Torres-Gonzalez P, Criollo E, et al. Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial. Transpl Infect Dis 2018;20(5):e12980.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Gomez MF, Padilla-Fernandez B, Garcia-Cenador MB, Virseda-Rodriguez AJ, Martin-Garcia I, Sanchez-Escudero A, et al. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections. Front Cell Infect Microbiol 2015;5:50.
   PubMedGoogle Scholar
• Lorenzo-Gomez MF, Padilla-Fernandez B, Garcia-Criado FJ, Miron-Canelo JA, Gil-Vicente A, Nieto-Huertos A, et al. Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infections versus prophylactic treatment with antibiotics. Int Urogynecol J 2013;24(1):127–134.
   PubMed Web of Science ®Google Scholar
• Yang B, Foley S. First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine uromune((R)). BJU Int 2018;121(2):289–292.
   PubMed Web of Science ®Google Scholar